Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Malonne

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
British Journal of Cancer|August 15, 2002
Differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humansH Malonne
Journal De Pharmacie De Belgique|January 1, 1997
[Drug interactions: I. General principles]H Malonne, J Fontaine
Journal De Pharmacie De Belgique|March 1, 1997
[Drug interactions. II. Examples encountered in the treatment of digestive pathologies]H Malonne, J Fontaine
Anti-Cancer Drugs|December 24, 1997
DNA topoisomerase targeting drugs: mechanisms of action and perspectivesH Malonne, G Atassi
Carcinogenesis|July 27, 2001
A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrolJ Gusman, H Malonne, G Atassi
Biological & Pharmaceutical Bulletin|May 24, 2000
In vitro/in vivo characterization of a tramadol HCl depot system composed of monoolein and waterH Malonne, J Fontaine, A Moës
Journal De Pharmacie De Belgique|November 1, 1996
[Treatment of pain at a community pharmacy]H Malonne, L Leemans, J Fontaine
Clinical & Experimental Metastasis|July 2, 1999
Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitorsH Malonne, I Langer, R Kiss, et al.
Anticancer Research|June 16, 1999
Characterization of biological features and chemosensitivity of a new experimental lung metastasis model originating from the MXT mouse mammary adenocarcinomaS Farinelle, R Dedecker, H Malonne, et al.
Fitoterapia|July 21, 2004
Cytotoxic constituents from Plumbago zeylanicaA T Nguyen, H Malonne, P Duez, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
British Journal of Cancer|August 15, 2002
Differences in efficacy found in animals between recombinant forms of erythropoietin will not necessarily translate into differences in humansH Malonne
Journal De Pharmacie De Belgique|January 1, 1997
[Drug interactions: I. General principles]H Malonne, J Fontaine
Journal De Pharmacie De Belgique|March 1, 1997
[Drug interactions. II. Examples encountered in the treatment of digestive pathologies]H Malonne, J Fontaine
Anti-Cancer Drugs|December 24, 1997
DNA topoisomerase targeting drugs: mechanisms of action and perspectivesH Malonne, G Atassi
Carcinogenesis|July 27, 2001
A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrolJ Gusman, H Malonne, G Atassi
Biological & Pharmaceutical Bulletin|May 24, 2000
In vitro/in vivo characterization of a tramadol HCl depot system composed of monoolein and waterH Malonne, J Fontaine, A Moës
Journal De Pharmacie De Belgique|November 1, 1996
[Treatment of pain at a community pharmacy]H Malonne, L Leemans, J Fontaine
Clinical & Experimental Metastasis|July 2, 1999
Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitorsH Malonne, I Langer, R Kiss, et al.
Anticancer Research|June 16, 1999
Characterization of biological features and chemosensitivity of a new experimental lung metastasis model originating from the MXT mouse mammary adenocarcinomaS Farinelle, R Dedecker, H Malonne, et al.
Fitoterapia|July 21, 2004
Cytotoxic constituents from Plumbago zeylanicaA T Nguyen, H Malonne, P Duez, et al.
Pageof 2